Buyer	DSIT — not a council we hold
Supplier	Resonance Alliance INC

To deliver on the broad opportunities presented by quantum technologies to reduce costs and save lives, quantum-enabled products and services will need to become integrated within our NHS. This mission will build on early UK successes in the development of products to revolutionise healthcare capabilities and pull these through to adoption, providing a firm foundation to grow the UK quantum medical device industry sector. The mission will also generate a pipeline of next-generation technologies which harness quantum physics to deliver early-stage diagnoses and improved surgical outcomes, across areas such as dementia, epilepsy, cancer, cardiovascular disease, infectious diseases, as well as quantum for life sciences and social care.

Runs	19 Jan 2025 to 19 Jun 2025
OCID	ocds-b5fd17-14613814-db40-484a-9f94-025db3bda8e1
Notice	Read it on Contracts Finder

Figures are as published An award value in OCDS may be a framework ceiling rather than a sum anyone expects to spend, so a large figure here is not evidence of a large purchase.